Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Yonsei University College of Medicine
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740522/ |